It is hypothesized that obesity causes metabolic abnormalities such as hypertension, glucose metabolic disorders, and dyslipidemia due to uncontrolled FFA release from adipose tissue and decreased insulin sensitivity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.